Idexx Laboratories (IDXX) Other Non-Current Liabilities (2009 - 2026)

Idexx Laboratories' Other Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $54.0 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 13.21% year-over-year to $54.0 million; the TTM figure through Mar 2026 stood at $54.0 million (up 13.21% YoY), while the FY2025 annual figure was $56.5 million, up 27.48% from the prior year.
• Other Non-Current Liabilities was $54.0 million for Q1 2026 at Idexx Laboratories, down from $56.5 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $71.8 million in Q1 2022 to a low of $44.3 million in Q4 2024.
• Historically, Other Non-Current Liabilities has averaged $61.2 million across 5 years, with a median of $62.9 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities slumped 32.33% in 2024, then advanced 27.48% in 2025.
• A 5-year view of Other Non-Current Liabilities shows it stood at $67.6 million in 2022, then dropped by 3.05% to $65.5 million in 2023, then plunged by 32.33% to $44.3 million in 2024, then rose by 27.48% to $56.5 million in 2025, then slipped by 4.41% to $54.0 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $54.0 million (Q1 2026), $56.5 million (Q4 2025), and $57.6 million (Q3 2025), per Business Quant data.